Baidu
map

消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2018 多伦多共识：肛周瘘管性克罗恩病的医学管理指南

2018-08-06 加拿大胃肠病学协会 Inflamm Bowel Dis. 2018 Aug 6.

肛周瘘管性克罗恩病医学管理

2018年8月，加拿大胃肠病学协会(CAG)发布了肛周瘘管性克罗恩病的医学管理指南的多伦多共识，约有25%的克罗恩病患者有瘘管发生且治疗困难，本文的主要目的是为肛周瘘管性克罗恩病的管理提供指导建议。

中文标题：

2018 多伦多共识：肛周瘘管性克罗恩病的医学管理指南

英文标题：

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn''s Disease: The Toronto Consensus.

发布机构：

加拿大胃肠病学协会

发布日期：

2018-08-06

简要介绍：

2018年8月，加拿大胃肠病学协会(CAG)发布了肛周瘘管性克罗恩病的医学管理指南的多伦多共识，约有25%的克罗恩病患者有瘘管发生且治疗困难，本文的主要目的是为肛周瘘管性克罗恩病的管理提供指导建议。 

拓展指南：与克罗恩病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 多伦多共识：肛周瘘管性克罗恩病的医学管理指南)] GetToolGuiderByIdResponse(projectId=1, id=7af621c00162837c, title=2018 多伦多共识：肛周瘘管性克罗恩病的医学管理指南, enTitle=Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn''s Disease: The Toronto Consensus., guiderFrom=Inflamm Bowel Dis. 2018 Aug 6., authorId=null, author=, summary=2018年8月，加拿大胃肠病学协会(CAG)发布了肛周瘘管性克罗恩病的医学管理指南的多伦多共识，约有25%的克罗恩病患者有瘘管发生且治疗困难，本文的主要目的是为肛周瘘管性克罗恩病的管理提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=716, associationName=加拿大胃肠病学协会, associationIntro=加拿大胃肠病学协会(CAG)成立于1962年，该协会现有成员1100多个，包括胃肠科医生，外科医生，儿科医生，基础研究者和护士等。协会的目的是进行消化道的健康和疾病研究，通过指导患者护理、教学、持续专业发展促进胃肠道科学发展，提倡并维护最高的道德标准。CAG注重教育职能，协会网站设有Physician Education栏目，为会员提供继续医学教育、培训项目等信息。 协会每年2月末都举办加拿大消化疾病周会议(CDDW)，分为临床和基础两个会场，参会人员包括胃肠病学、肝病学、内镜和胃肠外科等专业的医生和研究人员。CAG还注重患者教育，从首页可链接到加拿大消化道健康基金会(CDHF)为患者介绍消化系统疾病的相关知识。, copyright=0, guiderPublishedTime=Mon Aug 06 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年8月，加拿大胃肠病学协会(CAG)发布了肛周瘘管性克罗恩病的医学管理指南的多伦多共识，约有25%的克罗恩病患者有瘘管发生且治疗困难，本文的主要目的是为肛周瘘管性克罗恩病的管理提供指导建议。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>克罗恩病</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=217bf1c00160e225" title="2018 多学科专家共识：克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标" target=_blank>2018 多学科专家共识：克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=fccaa1c0015e71b8" title="2018 ACG临床指南：成人克罗恩病的管理" target=_blank>2018 ACG临床指南：成人克罗恩病的管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=8d9001c001a6e962" title="2017 台湾克罗恩病管理指南" target=_blank>2017 台湾克罗恩病管理指南</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=e28081c001a341c3" title="2017 ECCO/ESCP共识：克罗恩病的手术治疗" target=_blank>2017 ECCO/ESCP共识：克罗恩病的手术治疗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c60d51c001a1e4e0" title="2017 ACPGBI共识：克罗恩病肛周瘘管的手术治疗" target=_blank>2017 ACPGBI共识：克罗恩病肛周瘘管的手术治疗</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E5%85%8B%E7%BD%97%E6%81%A9%E7%97%85" target=_blank>有关克罗恩病更多指南</a></ul>, tagList=[TagDto(tagId=79226, tagName=肛周瘘管性克罗恩病), TagDto(tagId=71547, tagName=医学管理)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5206, appHits=142, showAppHits=0, pcHits=3907, showPcHits=1584, likes=116, shares=4, comments=4, approvalStatus=1, publishedTime=Thu Aug 16 22:02:39 CST 2018, publishedTimeString=2018-08-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Aug 16 22:02:39 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:07:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 多伦多共识：肛周瘘管性克罗恩病的医学管理指南)])
2018 多伦多共识：肛周瘘管性克罗恩病的医学管理指南
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=348260, encodeId=eeda3482605b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Oct 07 04:22:43 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339054, encodeId=3d4d339054aa, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Aug 16 23:51:57 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339044, encodeId=cc0a339044fe, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Thu Aug 16 23:46:56 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339035, encodeId=9aab339035aa, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Aug 16 23:39:04 CST 2018, time=2018-08-16, status=1, ipAttribution=)]
    2018-10-07 秀红

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=348260, encodeId=eeda3482605b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Oct 07 04:22:43 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339054, encodeId=3d4d339054aa, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Aug 16 23:51:57 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339044, encodeId=cc0a339044fe, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Thu Aug 16 23:46:56 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339035, encodeId=9aab339035aa, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Aug 16 23:39:04 CST 2018, time=2018-08-16, status=1, ipAttribution=)]
    2018-08-16 清风拂面

    谢谢分享学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=348260, encodeId=eeda3482605b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Oct 07 04:22:43 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339054, encodeId=3d4d339054aa, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Aug 16 23:51:57 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339044, encodeId=cc0a339044fe, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Thu Aug 16 23:46:56 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339035, encodeId=9aab339035aa, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Aug 16 23:39:04 CST 2018, time=2018-08-16, status=1, ipAttribution=)]
    2018-08-16 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=348260, encodeId=eeda3482605b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Oct 07 04:22:43 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339054, encodeId=3d4d339054aa, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Aug 16 23:51:57 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339044, encodeId=cc0a339044fe, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Thu Aug 16 23:46:56 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339035, encodeId=9aab339035aa, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Aug 16 23:39:04 CST 2018, time=2018-08-16, status=1, ipAttribution=)]
    2018-08-16 惠映实验室

    学习了，谢谢分享。

    0

Baidu
map
Baidu
map
Baidu
map